# OnCo record companion-002 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/companion-002/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "companion-002", "NCT05506943" ;
  schema:name "A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)"@en ;
  schema:alternateName "COMPANION-002"@en ;
  schema:description "A phase 2/3 trial testing Tovecimig in biliary tract cancer and bladder & urothelial cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/companion-002/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05506943> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2023-01-09" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/urothelial/> ;
  onco:drugs <https://onco.cc/drugs/tovecimig/> ;
  onco:companies <https://onco.cc/companies/compass-therapeutics/> .